drugset / Trial / NCT03400631

Changes in Cytokine Levels After Dextrose Injection in Stage IV Knee Osteoarthritis

NCT03400631

RandomizedParallel-groupQuadruple-blindBasic science

Summary

Twenty participants with severe arthritis will be enrolled. For the first week participants will either be injected with dextrose or just have fluid withdrawn for testing. The remaining participants will be given dextrose injection at the end of the week. After one week dextrose injections will be given at one, two, three, four, five, and six months. Fluid will be withdrawn from the knee at time zero, one week, and three months. The hypothesis is that dextrose injection will cause a change in proteins in the knee consistent with improved repair signals, along with improving knee pain and function. .

Timeline

Start
2018-08-01
Primary completion
2021-11-23
Completion
2021-11-23

Drugs

EvaluationDrugModalityDoseRoute
Subject Dextrose Unknown 10 ml Other
Subject Dextrose Unknown 12.5 % Other

Indications